• 1.

    Krawiec DR. Urethral diseases of dogs and cats. In: Osborne CA, Finco DR, eds. Canine and feline nephrology and urology. Baltimore: Lippincott Williams & Wilkins, 1995, 718725.

    • Search Google Scholar
    • Export Citation
  • 2.

    Stedile DA, Contesini ST, Oliveira CAC, et al. Urethral duplication in a dog: case report. Arq Bras Med Vet Zootec 2008; 60: 341345.

  • 3.

    Morris RK, Kilby MD. Congenital urinary tract obstruction. Best Pract Res Clin Obstet Gynaecol 2008; 22: 97122.

  • 4.

    Dewan PA, Goh DG. Variable expression of the congenital obstructive posterior urethral membrane. Urology 1995; 45: 507509.

  • 5.

    Wang KY, Samii VF, Chew DJ, et al. Vestibular, vaginal, and urethral relations in spayed dogs with and without lower urinary signs. J Vet Intern Med 2006; 20: 10651073.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 6.

    Holt PE, Sayle B. Congenital vestibulo-vaginal stenosis in the bitch. J Small Anim Pract 1981; 22: 6775.

  • 7.

    Wood MW, Vaden S, Cerda-Gonzalez S, et al. Cystoscopic-guided balloon dilation of a urethral stricture in a female dog. Can Vet J 2007; 48: 731733.

    • Search Google Scholar
    • Export Citation
  • 8.

    Bennett SL, Edwards GE, Tyrrell D. Balloon dilation of a urethral stricture in a dog. Aust Vet J 2005; 83: 552554.

  • 9.

    Dewan PA, Gotov E, Chiang D. Guide wire-assisted urethral dilation for urethral strictures in pediatric urology. J Pediatr Surg 2003; 38: 17901792.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 10.

    Brown SA, Williams JE, Saylor DK. Endotracheal stent granulation stenosis resolution after colchicine therapy in a dog. J Vet Intern Med 2008; 22: 10521055.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 11.

    Niel E, Scherrmann JM. Colchicine today. Joint Bone Spine 2006; 73: 672678.

  • 12.

    Ben-Chetrit E, Levy M. Colchicine: 1998 update. Semin Arthritis Rheum 1998; 28: 4859.

  • 13.

    Terkeltaub RA. Colchicine update: 2008. Semin Arthritis Rheum 2009; 38: 411419.

  • 14.

    Atta HM, El-Rehany MA, Abdel Raheim SR, et al. Colchicine inhibits intimal hyperplasia and leukocyte VEGF expression in dogs. J Surg Res 2008; 146: 184189.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 15.

    Fraune C, Gaschen F, Ryan K. Intralesional corticosteroid injection in addition to endoscopic balloon dilation in a dog with benign oesophageal strictures. J Small Anim Pract 2009; 10: 550553.

    • Search Google Scholar
    • Export Citation
  • 16.

    Webb CB, McCord KW, Twedt DC. Rectal strictures in 19 dogs: 1997–2005. J Am Anim Hosp Assoc 2007; 43: 332336.

  • 17.

    Ayyildiz A, Nuhoglu B, Gülerkaya B, et al. Effect of intraurethral mitomycin-C on healing and fibrosis in rats with experimentally induced urethral stricture. Int J Urol 2004; 11: 11221126.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 18.

    Türkılmaz Z, Sönmez K, Karabulut R, et al. Mitomycin C decreases the rate of stricture formation in caustic esophageal burns in rats. Surgery 2009; 145: 219225.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 19.

    Chung J, Connolly B, Langer J, et al. Fluoroscopy-guided topical application of mitomycin-C in a case of refractory esophageal stricture. J Vasc Interv Radiol 2010; 21: 152156.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 20.

    Heran MKS, Pham TH, Butterworth S, et al. Use of a microporuous polytetrafluoroethylene catheter balloon to treat refractory esophageal stricture: a novel technique for delivery of mitomycin C. J Ped Surg 2011; 46: 776779.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 21.

    Abbo AH, Jones DR, Masters AR, et al. Phase I clinical trial and pharmacokinetics of intravesical mitomycin C in dogs with localized transitional cell carcinoma of the urinary bladder. J Vet Intern Med 2010; 24: 11241130.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 22.

    Cave TA, Johnson V, Beths T, et al. Treatment of unresectable hepatocellular adenoma in dogs with transarterial iodized oil and chemotherapy with and without an embolic agent: a report of two cases. Vet Comp Oncol 2003; 1: 191199.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 23.

    Weisse C, Berent A, Todd K, et al. Evaluation of palliative stenting for management of malignant urethral obstructions in dogs. J Am Vet Med Assoc 2006; 229: 226234.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 24.

    Liptak JM, Brutscher SP, Monnet E, et al. Transurethral resection in the management of urethral and prostatic neoplasia in 6 dogs. Vet Surg 2004; 33: 505516.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 25.

    Elwick KE, Melendez LD, Higbee RG, et al. Neodymium:yttrium-aluminum-garnet (Nd:YAG) laser ablation of an obstructive urethral polyp in a dog. J Am Anim Hosp Assoc 2003; 39: 506508.

    • Crossref
    • Search Google Scholar
    • Export Citation

Advertisement

Dysuria caused by a partially obstructing urethral membrane in a female dog

Elizabeth S. LechnerDepartment of Small Animal Clinical Sciences, College of Veterinary Medicine, University of Florida, Gainesville, FL 32610.

Search for other papers by Elizabeth S. Lechner in
Current site
Google Scholar
PubMed
Close
 DVM
and
Kirsten L. CookeDepartment of Small Animal Clinical Sciences, College of Veterinary Medicine, University of Florida, Gainesville, FL 32610.

Search for other papers by Kirsten L. Cooke in
Current site
Google Scholar
PubMed
Close
 DVM, DACVIM

Abstract

Case Description—A 3.5-year-old spayed female Labrador Retriever was examined for dysuria of unknown duration.

Clinical Findings—Urogenital examination revealed a recessed vulva and a persistent hymen. The hymen was broken down digitally. Results of urinalysis at the referral examination were unremarkable, and no clinically relevant abnormalities were detected on clinicopathologic analysis of blood and serum samples or cytologic evaluation of a vaginal smear. After clinical signs persisted, retrograde contrast vaginourethrocystography was performed; results were considered normal. During uroendoscopic examination, a translucent membranous structure was detected that partially obstructed the urethral lumen near the junction of the urethra and bladder.

Treatment and Outcome—Passage of the endoscope into the urinary bladder ruptured the membranous structure. The dog recovered from the procedure uneventfully and was treated with colchicine (0.03 mg/kg [0.014 mg/lb], PO, q 24 h for 14 days). One month later, the owner reported resolution of clinical signs. Fourteen months later, the patient was evaluated for recurrence of dysuria of several months' duration. Uroendoscopic examination revealed a membranous structure similar to that originally detected; this tissue was also ruptured during endoscopy. The patient was discharged and the owner was instructed to administer colchicine at the same dosage. Recurrence of dysuria was reported again 10 months following the second procedure.

Clinical Relevance—To the authors' knowledge, this type of membranous urethral obstruction has not been previously described in a dog. Administration of colchicine did not prevent recurrence, but potential effects of drug administration on time to recurrence could not be evaluated.

Abstract

Case Description—A 3.5-year-old spayed female Labrador Retriever was examined for dysuria of unknown duration.

Clinical Findings—Urogenital examination revealed a recessed vulva and a persistent hymen. The hymen was broken down digitally. Results of urinalysis at the referral examination were unremarkable, and no clinically relevant abnormalities were detected on clinicopathologic analysis of blood and serum samples or cytologic evaluation of a vaginal smear. After clinical signs persisted, retrograde contrast vaginourethrocystography was performed; results were considered normal. During uroendoscopic examination, a translucent membranous structure was detected that partially obstructed the urethral lumen near the junction of the urethra and bladder.

Treatment and Outcome—Passage of the endoscope into the urinary bladder ruptured the membranous structure. The dog recovered from the procedure uneventfully and was treated with colchicine (0.03 mg/kg [0.014 mg/lb], PO, q 24 h for 14 days). One month later, the owner reported resolution of clinical signs. Fourteen months later, the patient was evaluated for recurrence of dysuria of several months' duration. Uroendoscopic examination revealed a membranous structure similar to that originally detected; this tissue was also ruptured during endoscopy. The patient was discharged and the owner was instructed to administer colchicine at the same dosage. Recurrence of dysuria was reported again 10 months following the second procedure.

Clinical Relevance—To the authors' knowledge, this type of membranous urethral obstruction has not been previously described in a dog. Administration of colchicine did not prevent recurrence, but potential effects of drug administration on time to recurrence could not be evaluated.

Contributor Notes

Dr. Lechner's present address is Palm Beach Veterinary Specialists, 3884 Forest Hill Blvd, West Palm Beach, FL 33406.

Address correspondence to Dr. Cooke (cookek@ufl.edu).